significantly lower – Page 30 – Communicable Diseases Research

Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease

경증 SARS-CoV-2 질병에서 좋지 않은 결과의 조기 대리 표지자로서의 유갑상선 질환 증후군

Article

Published on 2022-04-012022-09-11
Journal: Journal of Endocrinological Investigation [Category] 바이오마커,

[키워드] 95%CI analyses biochemical marker biochemical markers Biomarker Complete coronavirus correlated COVID-19 COVID-19 patient COVID-19 patients Cox regression Critical death died disease disorder early stage eligible eligible patient Eligible patients ESS euthyroid sick Euthyroid sick syndrome Evidence framework help Hospital admission Hospitalization Hospitalized ICU identify IL-6 increased risk Infection intensive care intensive care unit Kaplan-Meier Level Low fT3 marker medication Mild mild COVID-19 patients Mild disease Mild SARS-CoV-2 disease. New coronavirus outcome outcomes Patient patients Prognostic markers Prospective Prospective Study required SARS-CoV-2 disease screened sensitivity sick significantly lower specificity syndrome threshold Thyroid thyroid disease thyroid function transfer triiodothyronine were excluded with mild disease
[DOI] 10.1007/s40618-021-01714-1 PMC 바로가기 [Article Type] Article

Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation

동종 조혈 세포 이식 후 환자에서 SARS-CoV-2 백신 접종에 대한 항체 반응

Article

Published on 2022-04-012022-09-11
Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료법,

[키워드] age Allogeneic Allogeneic hematopoietic cell transplantation Analysis antibody antibody levels Antibody Response Antibody titer Antibody titers approved BNT162b2 Cell cell transplantation chronic GVHD Cohort conditioning regimen conducted Critical disease domain Efficacy examined Factor Graft-versus-host disease group GVHD had no healthy control healthy controls healthy volunteers hematopoietic Hematopoietic cell transplantation highest homogenous humoral immune response IgA IgG IgM immune response immune responses Immunocompromised patients Immunosuppression information intensity Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 nucleocapsid protein pandemic Patient physician reactivity receiving Receptor-binding domain recipient recipients regimen response revaccination S1 and S2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 pandemic SARS-CoV-2 vaccination second dose significantly lower single center spike glycoprotein stratified subunit Switzerland the SARS-CoV-2 the vaccine transplantation Treatment underlying disease vaccination Vaccine waned was performed
[DOI] 10.1016/j.jtct.2022.01.019 PMC 바로가기 [Article Type] Article

The association of statins use with survival of patients with COVID-19

Observational Study

Published on 2022-04-012022-10-05
Journal: Journal of cardiology [Category] COVID19(2023년), SARS, 임상,

Humoral response to SARS-CoV-2 infection among liver transplant recipients

간 이식 환자의 SARS-CoV-2 감염에 대한 체액 반응

Multicenter Study

Published on 2022-04-012022-09-11
Journal: Gut [Category] Coronavirus, COVID19(2023년), SARS, 치료기술, 치료법,

[키워드] anti-S antibody antibody Antibody Response Antibody testing Antibody titre assigned B lymphocytes case-control study Cohort cohorts controls COVID-19 COVID-19 symptom COVID-19 symptoms criteria detectable expected functional humoral Humoral response immune immune response Immunosuppression Immunosuppressive agents interfere less liver liver transplant Liver transplantation majority mounted multicentre neutralising ability Neutralising activity no difference nucleocapsid protein Patient Prospective Protein recipient recipients required SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-COV-2 infection Serologic response significantly lower subject Symptoms Testing the antibody response with COVID-19
[DOI] 10.1136/gutjnl-2021-326609 PMC 바로가기 [Article Type] Multicenter Study

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer

고형암으로 항암화학요법을 받는 환자에서 코로나19 백신 BNT162b2의 안전성과 면역원성

Article

Published on 2022-04-012022-09-12
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단,

[키워드] Adverse adverse event Anti-S1 antibody Antibody titer BNT162b2 BNT162b2 mRNA cancer patient Cancer patients Chemotherapy COVID-19 severity COVID-19 vaccine cytotoxic Cytotoxic chemotherapy dose ELISA evaluated group groups healthy volunteer immune Immune checkpoint chemotherapy Inflammatory cytokine inhibitor investigated Japan median no difference no significant difference not differ occurred of BNT162b2 Patient pre-vaccination reported S1 protein Safety SARS-CoV-2 vaccination second dose second vaccination Serious Adverse Event serum IgG significantly lower solid cancer therapy three groups vaccination
[DOI] 10.1016/j.jiac.2021.12.021 PMC 바로가기 [Article Type] Article

A telephonic survey of health-related quality of life of outpatient department dropout Parkinson’s disease patients during the COVID-19 pandemic

Observational Study

Published on 2022-04-012022-10-05
Journal: Acta neurologica Belgica [Category] 임상,

Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials

염증성 장 질환에서 원격 진료의 역할: 무작위 대조 시험의 체계적인 검토 및 메타 분석

Review

Published on 2022-03-242022-09-11
Journal: Journal of Medical Internet Research [Category] 임상,

[키워드] 95% CI abstracts Analysis benefit bowel Case report case reports Cochrane Library Controlled Controlled trial COVID-19 Data analysis database Depression disease Disease activity Effectiveness Efficiency groups IBD identify Inflammatory Inflammatory bowel disease Intervention Laboratory life management mean difference medication Meta-analysis mobile phone no significant difference no significant differences outcome pandemic Participants Patient Patient satisfaction Primary outcomes Psychological Quality of life Randomized controlled trial Randomized controlled trials Research review role searched Secondary outcomes Self-efficacy significantly higher significantly lower standard care standard care group Stata subgroup analysis systematic review Telemedicine Web of Science were assessed were excluded were used
[DOI] 10.2196/28978 PMC 바로가기 [Article Type] Review

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience

중화 모노클로날 항체 치료로 경증 및 중등도 코로나바이러스 질병 2019(COVID-19)로 인한 입원 감소: 실제 경험

Article

Published on 2022-03-232022-09-12
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단,

Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study

Research

Published on 2022-03-232022-10-05
Journal: European journal of clinical nutrition [Category] SARS, 치료법, 치료제,

Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection

SARS-CoV2 감염 환자를 검출하는 데 있어 WHO에서 승인한 두 가지 SARS-CoV2 항원 분석의 민감도 및 특이성

Article

Published on 2022-03-222022-09-11
Journal: BMC Infectious Diseases [Category] MERS, SARS, 진단, 치료기술,